Johnson & Johnson
Recent News About Johnson & Johnson
-
J&J calls Oklahoma's opioid case a 'legal miscarriage and practical fiasco' in motion for judgment
NORMAN, Okla. (Legal Newsline) - Immediately after Oklahoma closed its case against Johnson & Johnson, the company last week filed a motion seeking judgment in its favor, telling the judge who is overseeing a trial that has lasted five weeks that the State failed to prove J&J caused the state’s opioid crisis. -
Doctor testifying for J&J won’t use the E-word in Oklahoma opioid trial
NORMAN, Okla. (Legal Newsline) – An Oklahoma doctor appearing as a witness for Johnson & Johnson on Wednesday under questioning by state attorneys refused to use the word “epidemic” to describe the state’s opioid crisis, but conceded opioid overdose deaths had gone up in recent years. -
At Okla. opioid trial, Janssen sales rep says opioid products good, but state says drugs deadly
NORMAN, Okla. (Legal Newsline) – A sales representative for Janssen Pharmaceuticals on Tuesday told a courtroom his company sold opioid drug products that were safe and effective, while attorneys for the State of Oklahoma contended the company harmed the public for profit. -
J&J attorneys bring witness to counter Kolodny in Oklahoma opioid trial
NORMAN, Okla. (Legal Newsline) – Attorneys defending Johnson & Johnson in a trial accusing the company of creating an opioid drug crisis in Oklahoma on Monday brought in an expert witness to counter the testimony of Dr. Andrew Kolodny - a witness the company has alleged is a "de facto" member of the State's legal team. -
Janssen says addicts would have struggled to snort its opioids; Nucynta broke coffee grinder during testing
NORMAN, Okla. (Legal Newsline) – A former researcher with Janssen Pharmaceuticals, the drug subsidiary of Johnson & Johnson, on Friday said the company’s opioid products were safe if used properly, while attorneys hired by Oklahoma alleged J&J had played loose with the facts. -
Proposed opioid 'negotiation class' is unnecessary and likely to fail, former negotiator says
CLEVELAND (Legal Newsline) - A proposed opioid “negotiation class” that would include more than 24,000 U.S. cities and counties is a waste of judicial resources unlikely to achieve its stated goal of hammering out a global settlement, say critics, including a former Connecticut official who was directly involved in negotiations with the opioid industry. -
J&J says it wasn't given chance to prepare for witness called by Oklahoma in opioid trial
NORMAN, Okla, (Legal Newsline) – Attorneys for Johnson & Johnson and its opioid drug manufacturer Janssen Pharmaceutics on June 19 asked Cleveland Country District Court Judge Thad Balkman to decide if the testimony of a Connecticut businessman who founded a nonprofit to fight drug abuse should be allowed as evidence in a trial accusing the companies of creating a drug epidemic. -
Janssen defense witness at Oklahoma trial: Opioid drugs safe, effective when used properly
NORMAN, Okla. (Legal Newsline) – An opioid researcher called as a defense expert witness told a courtroom that the opioid medication Duragesic produced by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, had been approved by the Food and Drug Administration (FDA) because the benefits of the drug outweighed the risk. -
J&J points to small number of claims for its opioid products as it defends self in Okla. trial
NORMAN, Okla. (Legal Newsline) - Attorneys defending Johnson & Johnson made a case on Wednesday that drug abusers and irresponsible doctors share responsibility for an opioid overdose epidemic, while a top state health official repeated her opinion that overzealous J&J officials and sales reps were to blame. -
Okla. health official takes stand in opioid trial, says she doesn't remember the year J&J's unbranded marketing began
NORMAN, Okla. (Legal Newsline) – Oklahoma's top health officer told a courtroom on Tuesday that Johnson & Johnson preyed on the state’s citizens to sell opioid prescription drugs for profit, while attorneys for the company challenged the timeline in her head. -
J&J wonders why it should foot bill for addicts who never used its opioids
NORMAN, Okla. (Legal Newsline) – The attorney for Johnson & Johnson and its drug subsidiary Janssen Pharmaceuticals on Monday attempted to convince an Oklahoma judge that making the companies pay for a drug crisis, including addicts who never used their products or who used illegal drugs, is unfair. -
Oklahoma governor, AG resolve dispute over where $85M from opioid settlement should go
NORMAN, Okla. (Legal Newsline) – An Oklahoma judge announced on Monday agreement has been reached between feuding government officials on how an $85 million settlement with opioid drug maker Teva Pharmaceutical Co. would be apportioned. -
At Okla. opioid trial, mental health officer walks court through the proposed massive abatement plan
NORMAN, Okla. (Legal Newsline) – An idea of how much money Oklahoma wants to abate the opioid drug epidemic was realized on Friday as a state health officer walked officials through a 65-page list of abatement services she said were needed, collectively projected to cost in the billions. -
OSU executive director outlines opioid abatement improvements for Oklahoma campuses
NORMAN, Okla. (Legal Newsline) – In a trial to determine if Johnson & Johnson helped to cause an opioid epidemic, a health officer with the Oklahoma State University in Tulsa on Thursday said the addiction outbreak will cost millions of dollars to alleviate and decades to see major progress.. -
New York court strikes down $7M talc/asbestos verdict, says plaintiff's evidence was lacking
NEW YORK (Legal Newsline) - In an encouraging sign for talcum powder manufacturers facing a new wave of asbestos litigation in New York, a state appeals court has thrown out a 2017 jury verdict in a talc case because the plaintiff’s experts failed to explain how she could have contracted cancer from the cosmetic powder. -
A juror claimed there was a 'child game' happening within the jury that nailed J&J with a huge asbestos verdict
NEW YORK (Legal Newsline) - A $325 million jury verdict in a talcum powder/asbestos case was recently issued against Johnson & Johnson after one juror complained deliberations had been hijacked by others on the jury, and it is unlikely to survive appellate review, an expert says. -
Oklahoma's case against J&J includes video of baby quivering from opioid withdrawal
NORMAN, Okla. (Legal Newsline) – The State of Oklahoma's evidence in a closely watched opioid trial versus Johnson & Johnson was again emotionally charged on Wednesday, as attorneys hired by the state attorney general showed a video of a baby quivering from opioid withdrawal. -
Oklahoma's case turns emotional in opioid trial vs. Johnson & Johnson
NORMAN, Okla. (Legal Newsline) – A Connecticut businessman recounting the heartbreak of his son’s death from drug addiction on Tuesday outlined steps to end the stigma of the disease and to make treatment improvements in a trial to determine if Johnson & Johnson helped cause a prescription opioid epidemic. -
At opioid trial, Johnson & Johnson moves to strike Oklahoma witness as 'de facto member of State's legal team'
NORMAN, Okla. (Legal Newsline) - Johnson & Johnson has asked the judge overseeing the first in an expected wave of trials against the opioid industry to strike the testimony of Dr. Andrew Kolodny, a psychiatrist who plays a central role in the State of Oklahoma’s case by linking narcotics marketing to opioid addiction and overdose deaths. -
J&J's lawyers note opioids researcher being paid hundreds of thousands for testimony in Oklahoma trial
NORMAN, Okla. (Legal Newsline) – Attorneys defending Johnson & Johnson on Monday fended off accusations their client caused an addiction crisis and shifted attention onto Purdue Pharma, while also noting a plaintiffs expert is being paid upward of $500,000 for his testimony.